Tim Close Joins Replenish Board as SRC's 19.9% Stake Turns From Headline to Real Control Test

SRC's stake and board seat make the partnership more concrete

This is more than a partnership headline. SRC now has both equity exposure and board representation at Replenish.

SRC owns a 19.9% non-diluted interest, and Tim Close joined the board effective July 30 under SRC's nominee rights. That moves the relationship from a strategic announcement into governance.

The next catalyst is the debenture close

Replenish has already closed the $7.5 million equity portion, and the convertible debenture investment is expected to close on or about August 14, 2026. When that closes, SRC's board rights increase to two directors, which is the clearest near-term control milestone in the story.

Bulls can read that as de-risking: capital is in place, SRC has a meaningful voting block, and SRC moves from supporter to decision-maker before execution is fully proven. Bears can counter that one equity close and one board nominee do not yet prove operations, supply-chain success, or management discipline. The key point is timing: the next shift in board power arrives with the debenture close, not sometime later.

Tim Close matters because the role links capital to execution

SRC is not just taking a seat at the table. It is linking financing, strategy, and oversight more directly to Replenish's next operating phase.

The execution signal comes from Close's background

He is previously served as CEO of Ag Growth International, and SRC says he brings expertise in capital markets, corporate strategy, operational execution and commercial governance. For a company still trying to turn a technology story into repeatable commercial execution, that background is the part of the appointment investors should focus on.

The use-of-proceeds map makes progress easier to grade

Replenish said net proceeds will fund the Beiseker Pelletization Expansion, plus working capital, inventory purchases, debt repayment, and general corporate purposes. That gives investors a clearer scoreboard than a broad strategic narrative alone.

The scoreboard gets clearer after the debenture closes. SRC's board rights would then increase to two directors, which could make budget review, project timing, and management follow-through more visible.

The carbonatite supply agreement adds another operational lever

Replenish also entered into a 10-year supply agreement with SRC for the supply and delivery of carbonatite from the Spanish River deposit. SRC says the deposit is distinguished by high concentrations of loosely bonded calcium, phosphorus, potassium and magnesium, along with trace rare earth elements, and without the radioactive or toxic heavy metals found in many other carbonatite deposits.

If that agreement improves feedstock access or delivery certainty, it strengthens the case that this is becoming an operating buildout rather than only a strategic narrative.

Replenish still has to prove scale economics before losses dominate the story

Governance matters only if operations improve faster than financial pressure builds.

The 2025 results were mixed

Full-year 2025 revenue was essentially flat at $6.8 million versus $6.9 million. Full-year gross profit fell to $192,290 from $639,055, and net loss widened to $8.6 million from $4.3 million. Replenish attributed the larger loss to higher finance costs tied to increased debt levels, as well as the absence of one-time gains and tax recoveries recorded in the prior year.

There was some positive movement in the mix. Q4 2025 revenue rose to $3 million from $2.6 million a year earlier, and management said the Beiseker facility is ramping toward 2,000 metric tonnes per month. But the income-statement trend still argues that scale benefits have not fully arrived.

The upside case depends on manufacturing and licensing scale

The bullish case gets stronger only if Replenish can translate its manufacturing base into durable throughput. Beyond Beiseker, Replenish is advancing licensing agreements with Farmers Unio and has referenced additional licensed capacity that could expand output significantly.

That is the real upside path: moving from a niche producer toward a larger regional manufacturer. But it remains a future operating scenario. It does not erase the fact that the company is still funding that buildout while losses remain elevated.

The Aug. 14 debenture close is the first real test

The stock's move to $0.150 CAD from $0.045 CAD earlier this spring shows the market has already responded to the strategic setup. The next checkpoint is whether SRC's deeper involvement actually closes.

What would confirm the thesis

The next meaningful checkpoint is the convertible debenture investment expected around August 14, 2026. If that closes, SRC's board rights increase to two directors, and the story shifts closer to active oversight than strategic interest.

Watch for: - a debenture close near the expected date - SRC's board representation increasing to two directors - visible progress on the Beiseker Pelletization Expansion - clearer operating follow-through as Replenish continues transitioning toward commercialization

What would weaken the setup

This setup weakens quickly if: - the debenture slips or the arrangement becomes less hands-on - the company continues reporting continued net losses as the company transitions toward commercialization without a visible turnaround in gross profit or operating leverage

If execution improves, the recent move may look early. If not, the stock is likely to remain driven more by narrative than by operating proof.